109 related articles for article (PubMed ID: 32372701)
1. Current status of lung cancer in Spain: a retrospective analysis of patient characteristics, use of healthcare resources and in-hospital mortality.
Darbà J; Marsà A
Curr Med Res Opin; 2020 Jul; 36(7):1201-1207. PubMed ID: 32372701
[No Abstract] [Full Text] [Related]
2. Patient characteristics and hospitalisation costs of spinal muscular atrophy in Spain: a retrospective multicentre database analysis.
Darbà J; Marsà A
BMJ Open; 2019 Nov; 9(11):e031271. PubMed ID: 31753879
[TBL] [Abstract][Full Text] [Related]
3. Incidence, mortality and medical costs of patients hospitalized with melanoma in Spain: a retrospective multicentre observational study.
Darbà J; Marsà A
Curr Med Res Opin; 2021 May; 37(5):795-800. PubMed ID: 33591848
[TBL] [Abstract][Full Text] [Related]
4. Estimation of lung cancer diagnosis and treatment costs based on a patient-level analysis in Catalonia (Spain).
Corral J; Espinàs JA; Cots F; Pareja L; Solà J; Font R; Borràs JM
BMC Health Serv Res; 2015 Feb; 15():70. PubMed ID: 25889153
[TBL] [Abstract][Full Text] [Related]
5. Hospital incidence, in-hospital mortality and medical costs of pneumococcal disease in Spain (2008-2017): a retrospective multicentre study.
Darbà J; Marsà A
Curr Med Res Opin; 2021 Mar; 37(3):523-530. PubMed ID: 33459058
[TBL] [Abstract][Full Text] [Related]
6. Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study.
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1101-1106. PubMed ID: 32928002
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, management and costs of sepsis in Spain (2008-2017): a retrospective multicentre study.
Darbà J; Marsà A
Curr Med Res Opin; 2020 Jul; 36(7):1089-1095. PubMed ID: 32329375
[No Abstract] [Full Text] [Related]
8. Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011-2017).
Darbà J; Marsà A
J Med Econ; 2020 Dec; 23(12):1623-1629. PubMed ID: 33000981
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit.
Bonomi MR; Smith CB; Mhango G; Wisnivesky JP
Lung Cancer; 2012 Sep; 77(3):600-4. PubMed ID: 22709929
[TBL] [Abstract][Full Text] [Related]
10. Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
Lee DH; Isobe H; Wirtz H; Aleixo SB; Parente P; de Marinis F; Huang M; Arunachalam A; Kothari S; Cao X; Donnini N; Woodgate AM; de Castro J
BMC Health Serv Res; 2018 Mar; 18(1):147. PubMed ID: 29490654
[TBL] [Abstract][Full Text] [Related]
11. Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
Darbà J; Marsà A
BMC Cancer; 2019 Dec; 19(1):1226. PubMed ID: 31842791
[TBL] [Abstract][Full Text] [Related]
12. Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis.
Darbà J; Marsà A
Expert Rev Pharmacoecon Outcomes Res; 2022 Sep; 22(6):965-970. PubMed ID: 35034517
[TBL] [Abstract][Full Text] [Related]
13. Outcome and code status of lung cancer patients admitted to the medical ICU.
Reichner CA; Thompson JA; O'Brien S; Kuru T; Anderson ED
Chest; 2006 Sep; 130(3):719-23. PubMed ID: 16963668
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and management of parathyroid gland disorders in Spain over 15 years: A retrospective multicentre analysis.
Darbà J; Marsà A
PLoS One; 2020; 15(3):e0230130. PubMed ID: 32155210
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, management and medical costs of patients with depressive disorders admitted in primary and specialised care centres in Spain between 2011 and 2016.
Darbà J; Marsà A
PLoS One; 2020; 15(2):e0228749. PubMed ID: 32023308
[TBL] [Abstract][Full Text] [Related]
16. Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016).
Darbà J; Marsà A
PLoS One; 2020; 15(2):e0228795. PubMed ID: 32040530
[TBL] [Abstract][Full Text] [Related]
17. Palliative care units in lung cancer in the real-world setting: a single institution's experience and its implications.
Masel EK; Schur S; Nemecek R; Mayrhofer M; Huber P; Adamidis F; Maehr B; Unseld M; Watzke HH; Pirker R
Ann Palliat Med; 2017 Jan; 6(1):6-13. PubMed ID: 27701880
[TBL] [Abstract][Full Text] [Related]
18. Management and costs of treating lung cancer patients in a university hospital.
Dedes KJ; Szucs TD; Bodis S; Joerger M; Lowy A; Russi EW; Steinert HC; Weder W; Stahel RA
Pharmacoeconomics; 2004; 22(7):435-44. PubMed ID: 15137882
[TBL] [Abstract][Full Text] [Related]
19. [Clinical care characteristics and factors associated with in-hospital mortality for lung cancer in Spain].
Sendra-Gutiérrez JM; Palma-Ruiz M; Martín-Martínez MA; Sarría-Santamera A
Med Clin (Barc); 2009 Jun; 133(1):8-16. PubMed ID: 19368941
[TBL] [Abstract][Full Text] [Related]
20. Implementation of optimized supportive care and hospital needs along the management of patients with advanced lung cancer.
Lafitte C; Etienne-Mastroianni B; Fournel C; Natoli L; Foucaut AM; Girard N
Lung Cancer; 2018 Oct; 124():143-147. PubMed ID: 30268453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
